Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Update on biosimilars in rheumatology.
Rischin A, Östör AJ. Rischin A, et al. Inflammopharmacology. 2017 Apr;25(2):177-184. doi: 10.1007/s10787-017-0333-4. Epub 2017 Mar 7. Inflammopharmacology. 2017. PMID: 28265837 Review.
Baseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy: data from the Australian rheumatology association database.
Briggs AM, March L, Lassere M, Reid C, Henderson L, Murphy B, van den Haak R, Rischin A, Staples M, Buchbinder R. Briggs AM, et al. Among authors: rischin a. Int J Rheumatol. 2009;2009:861481. doi: 10.1155/2009/861481. Epub 2009 Sep 1. Int J Rheumatol. 2009. PMID: 20130803 Free PMC article.
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.
Mitchell EL, Lau PKH, Khoo C, Liew D, Leung J, Liu B, Rischin A, Frauman AG, Kee D, Smith K, Brady B, Rischin D, Gibson A, Mileshkin L, Klein O, Weickhardt A, Arulananda S, Shackleton M, McArthur G, Östör A, Cebon J, Solomon B, Buchanan RR, Wicks IP, Lo S, Hicks RJ, Sandhu S. Mitchell EL, et al. Among authors: rischin a. Eur J Cancer. 2018 Dec;105:88-102. doi: 10.1016/j.ejca.2018.09.027. Epub 2018 Nov 13. Eur J Cancer. 2018. PMID: 30439628